Quest for the right Drug

|
עמוד הבית / פריוריקס טטרה / מידע מעלון לרופא

פריוריקס טטרה PRIORIX TETRA (LIVE ATTENUATED MEASLES VIRUS, LIVE ATTENUATED MUMPS VIRUS, LIVE ATTENUATED RUBELLA VACCINE, LIVE ATTENUATED RUBELLA VIRUS, LIVE ATTENUATED VARICELLA VIRUS, VARICELLA VIRUS, LIVE ATTENUATED)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תת-עורי : S.C

צורת מינון:

אבקה וממס להכנת תמיסה להזרקה : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Posology : מינונים

4.2   Posology and method of administration

Posology

Children from 12 months up to 12 years
Infants and children aged from 12 months up to 12 years should receive two doses (each of 0.5 ml) of Priorix-Tetra. The age at which infants or children may receive Priorix Tetra should reflect applicable official recommendations*, which vary according to the epidemiology of these diseases.

The dose interval should preferably* be between 6 weeks and 3 months. When the first dose is administered at 11 months of age, the second dose should be administered within 3 months. Under no circumstances should the dose interval be less than 4 weeks. See section 5.1.

Alternatively, and in accordance with applicable official recommendations*: -     A single dose of Priorix Tetra may be administered to children who have already received a single dose of another measles, mumps and rubella (MMR) vaccine and/or a single dose of another varicella vaccine
-     A single dose of Priorix Tetra may be administered followed by a single dose of another measles, mumps and rubella (MMR) vaccine and/or a single dose of another varicella vaccine 
* Applicable official recommendations may vary regarding the interval between doses and the need for two or one doses of measles, mumps and rubella and of varicella-containing vaccines.

Children from 9 to 11 months
In case an epidemiological situation requires vaccinating infants less than 12 months of age, the first dose of Priorix Tetra can be given as from 9 months of age. A second dose of Priorix Tetra should be given three months after the first dose (see section 5.1).

Method of administration

The vaccine is to be injected by the subcutaneous route in the deltoid region of the upper arm or in the higher anterolateral area of the thigh.

For instructions on reconstitution of the medicinal product before administration, see section 6.6.

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

GLAXO SMITH KLINE (ISRAEL) LTD

רישום

138 98 31847 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

10.01.18 - עלון לרופא 26.02.23 - עלון לרופא

עלון מידע לצרכן

31.10.12 - עלון לצרכן 02.08.13 - עלון לצרכן 05.01.15 - עלון לצרכן 11.07.16 - עלון לצרכן 19.12.17 - עלון לצרכן 29.11.11 - החמרה לעלון

לתרופה במאגר משרד הבריאות

פריוריקס טטרה

קישורים נוספים

RxList WebMD Drugs.com